Prostaglandin F2-alpha (PGF2α) in Vitiligo
NCT03755830 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2018-11-28
Summary
study the cutaneous expression of PGF2α in vitiligo patients and compare it with normal control subjects.
Conditions
- Vitiligo
Interventions
- OTHER
-
Skin biopsy
Two skin biopsies (lesional and non-lesional) will be taken from every patient. Also a skin biopsy will be taken from each control subject.
Sponsors & Collaborators
-
Cairo University
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-12-31
- Primary Completion
- 2019-07-31
- Completion
- 2019-07-31
More Related Trials
-
Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo
NCT03371758 ·Status: UNKNOWN ·Phase: NA
-
Janus Kinase 1 in Vitiligo & Psoriasis
NCT03762551 ·Status: COMPLETED ·Phase: NA
-
Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo
NCT06410898 ·Status: RECRUITING ·Phase: NA
-
Gene Polymorphism in Tinea Versicolor
NCT04769804 ·Status: UNKNOWN
-
Human Beta-defensin 1 in Vitiligo
NCT03832751 ·Status: UNKNOWN ·Phase: NA
-
Leucotrichia in Vitiligo
NCT03402633 ·Status: COMPLETED
-
Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo
NCT04320160 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: UNKNOWN
-
Stress Response Pathways in Vitiligo
NCT02797574 ·Status: COMPLETED ·Phase: NA
-
Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles
NCT07298551 ·Status: NOT_YET_RECRUITING
-
E-cadherin and Integrin Alpha v Beta 1 in Vitiligo
NCT05287776 ·Status: UNKNOWN ·Phase: NA
-
TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo Patients
NCT07232238 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
NCT04892381 ·Status: UNKNOWN
-
Thymic Stromal Lymphopoietin (TSLP) in Vitiligo
NCT03367273 ·Status: COMPLETED ·Phase: NA
-
Long-term Follow-up in Patients Affected With Acrofacial Vitiligo
NCT01459055 ·Status: UNKNOWN
-
Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study
NCT05855460 ·Status: UNKNOWN
-
Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo
NCT05121532 ·Status: UNKNOWN ·Phase: NA
-
The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity
NCT03741738 ·Status: COMPLETED
-
Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients
NCT06261073 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Photoprotection Habits in Patients With Vitiligo
NCT03323125 ·Status: COMPLETED
-
Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides
NCT05526638 ·Status: UNKNOWN ·Phase: NA
-
ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO
NCT05990309 ·Status: UNKNOWN ·Phase: NA
-
Resident Memory T Cells in Vitiligo
NCT05223738 ·Status: UNKNOWN
-
Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
NCT07015060 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diagnostic Role of Renal Biopsy in Patients With Fabry Disease
NCT06801288 ·Status: COMPLETED